Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2025 Earnings Call Transcript February 26, 2026
Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2.74, expectations were $-0.09.
Operator: Hello, and welcome to Phathom Pharmaceuticals Fourth Quarter and Full Year 2025 Earnings Results Call. [Operator Instructions] Please be advised that today’s call is being recorded. With that, I would like to turn the call over to Eric Sciorilli, Phathom’s Head of Investor...
